Neuroimmune crosstalk in joint pain: Understanding the role of inflammation and macrophages
Joint pain, a hallmark of conditions like rheumatoid arthritis (RA), osteoarthritis (OA), and aseptic loosening (AL), is deeply rooted in the complex neuroimmune interplay. This dynamic interaction involves immune cells, inflammatory mediators, and sensory nerves, all contributing to the genesis and persistence of pain. Among these, macrophages play a pivotal role as mediators of inflammation and pain signaling.
Inflammation in joint disorders triggers the release of cytokines, chemokines, and other mediators, sensitizing nociceptors and amplifying pain responses. In turn, sensory nerves release neurotransmitters like substance P and calcitonin gene-related peptide (CGRP), which modulate immune cell activity and exacerbate inflammation. Macrophages, central to this process, act as a bridge, responding to nerve signals and secreting pro-inflammatory factors such as IL-1β and TNF-α, which further activate nociceptors.
The dual nature of macrophages, capable of both inflammatory (M1) and reparative (M2) phenotypes, highlights their versatility. However, their dysregulated activity in chronic conditions sustains low-grade inflammation and joint destruction. Targeting macrophage function has shown promise in reducing pain and inflammation, with studies demonstrating decreased pain behaviors following macrophage depletion or modulation in experimental models.
Additionally, alterations in joint innervation patterns, including nerve sprouting or loss of sympathetic fibers, have been linked to pain severity and inflammatory progression. These changes emphasize the bidirectional nature of neuroimmune crosstalk, where inflammation and nerve signaling perpetuate each other.
Understanding the interplay between immune cells and sensory nerves offers new therapeutic avenues. By modulating neuroimmune interactions, there is potential to develop more effective treatments for chronic joint pain, improving the quality of life for those affected.